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FEBS Letters 580 (2006) 1Frances Shannon grew up in Ireland. After ﬁnishing her PhD,
she moved to Australia where she has lived and worked ever
since. ‘‘Australia is a great place to live. It is a big, spacious
country, long drives between cities, at least compared to Ire-
land.’’ She is currently a professor and Head of the Division
of Molecular Biosciences at The John Curtin School of Medi-
cal Research at the Australian National University in Can-
berra. Frances edits papers for FEBS Letters in the ﬁelds of
gene transcription regulation, molecular immunology and
epigenetics.
What is Canberra like?
Canberra is a beautiful and well-designed city. It is a great
place to enjoy the outdoors and wonderful for a young
family. It is small by Australian standards, only 300000
people, whereas Sydney and Melbourne each have several
million.
What does your lab do?
We are interested in how genes are switched on and oﬀ in cells,
in particular how transcription factors gain access to the DNA
through all this mush of stuﬀ in the nucleus. A more scientiﬁc
description would be to say that we study the eﬀect of chroma-
tin structure on gene transcription, mapping the changes in
chromatin structure and relating these to the availability of
transcription factors and signalling molecules.
How do you do this?
We use the immune system as a model. When T cells are acti-
vated, hundreds of genes are turned on and within 24 h many
are turned oﬀ again. Using quantitative PCR, we can look at
how the structure of chromatin changes during this process.
One of my PhD students, Xinxin Chen, recently found that
the bound histone levels dramatically decrease at the promoter
or enhancer regions of these highly inducible genes when acti-
vation occurs [1]. This is a very novel ﬁnding, and we are wait-
ing to see how widespread this phenomenon is. We also
identify groups of co-regulated genes using microarrays. One
of our models systems is NF-jB, an important transcription
factor in cancer and immune-related diseases. Using both com-
putational and experimental approaches, we deﬁne common
chromatin components and transcription factor combinations
that drive co-regulation with NF-jB.
What is your philosophy of leadership?
I try to give my students and post-docs a sense for what is really
involved in progressing through the diﬀerent stages of a0014-5793/$32.00  2005 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2005.11.009scientiﬁc career. I like to encourage them to be independent
and to help them realize that their own input determines what
they will achieve. Science is very much a self-motivated
business.
Do you have a favourite article?
Mine or somebody elses? One of my own favourites is the sec-
ond paper I ever published; it was accepted without any cor-
rections [2]. It was one of those early experiences in your
career where you think this research business is easy (laugh-
ing). In another favourite, one of my post-docs, Roy Himes,
discovered that two diﬀerent NF-jB proteins were involved
in activating a cytokine gene at diﬀerent times [3]. It had not
dawned on us before that timing would make such a diﬀerence.
Roy also found that a chromatin-binding protein aﬀected the
function of one (c-Rel) but not the other (RelA) NF-jB.
Again, this paper was published with very few corrections,
another joyful experience.
In retrospect, why do you think these papers were accepted
straight-away?
I think they were well written, the timing was right for the sci-
entiﬁc audience and they were pitched at a journal that was
exactly at the right level.
Why is your 1994 Journal of Immunology paper so highly cited?
[4]
This paper describes an early example of synergistic tran-
scription on an inducible gene promoter. We showed that
an NF-jB binding site in the IL-8 gene promoter cooperated
with an adjacent binding site for a member of the CEBP
family of transcription factors. Actually, this was the second
paper we published in this general vein, the other was never
as highly cited [5]. I am not sure why. Two papers with
similar messages published at the same time, and one is
picked up and cited more, it is one of those little quirks in
science.
Do you have advice for people who want to become an academic?
Do it, it is a fantastic job. If you are interested in new knowl-
edge and new information, I reckon theres no better career
than being a researcher.
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